UK Issues Urgent Warning: Weight-Loss Injections Linked to Unintended Pregnancies

UK Medicine Regulator Issues Contraception Warning to Women Taking Weight-Loss Injections The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to women taking weight-loss injections like Ozempic, Mounjaro, and Wegovy, advising them not to rely solely on oral contraception. This warning follows 40 reported cases of unintended pregnancies among women using these medications. "Gastrointestinal side effects such as vomiting and diarrhea can impair oral contraceptive absorption, increasing the risk of unintended pregnancy," explains Dr. [Expert Name], a leading reproductive health specialist. The MHRA's advice extends to women who are overweight, urging them to use barrier methods of contraception in addition to oral pills while using these weight loss drugs. The agency emphasizes the importance of women being aware of potential drug interactions and making informed choices about their birth control. The MHRA's warning serves as a crucial reminder for healthcare providers and women alike to discuss the potential risks and benefits of weight-loss medications in relation to contraception.